Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

Nature Medicine

Volumn 9, Issue 9, 2003, Pages 1195-1201

  Mangi, Abeel A ^a   Noiseux, Nicolas ^a   Kong, Deling ^a   He, Huamei ^a   Rezvani, Mojgan ^a   Ingwall, Joanne S ^a   Dzau, Victor J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; DIASTOLE; GENE OVEREXPRESSION; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HEART VENTRICLE REMODELING; IMMUNOCYTOCHEMISTRY; MESENCHYME CELL; MUSCLE MASS; MUSCLE REGENERATION; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RETROVIRUS; STEM CELL TRANSPLANTATION; SYSTOLE; TECHNIQUE; TISSUE REPAIR;

ANIMALS; APOPTOSIS; BETA-GALACTOSIDASE; BIOLOGICAL MARKERS; CELLS, CULTURED; COLLAGEN; HEMATOPOIETIC STEM CELLS; INJECTIONS; MALE; MESODERM; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RETROVIRIDAE; STEM CELL TRANSPLANTATION; TRANSDUCTION, GENETIC;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0141796313     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm912     Document Type: Article

References (45)

1. Williams, R.S. & Benjamin, I.J. Protective responses in the ischemic myocardium. J. Clin. Invest. 106, 813-818 (2000).
2. Pfeffer, J.M., Pfeffer, M.A., Fletcher, P.J. & Braunwald, E. Progressive ventricular remodeling in rat with myocardial infarction. Am. J. Physiol. 260, H1406-1414 (1991).
3. Beltrami, A.P. et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344, 1750-1757 (2001).
4. Jackson, K.A. et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107, 1395-1402 (2001).
5. Quaini, F. et al. Chimerism of the transplanted heart. N. Engl. J. Med. 346, 5-15 (2002).
6. Tomita, S. et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100, 11247-256 (1999).
7. Wang, J.S. et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J. Thorac. Cardiovasc. Surg. 120, 999-1005 (2000).
8. Orlic, D. et al. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (2001).
9. Kocher, A.A. et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436 (2001).
10. Kawamoto, A. et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103, 634-637 (2001).
11. Pereira, R.F. et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc. Natl. Acad. Sci. USA 92, 4857-4861 (1995).
12. Azizi, S.A. et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats - similarities to astrocyte grafts. Proc. Natl. Acad. Sci. USA 95, 3908-3913 (1998).
13. Chen, J. et al. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci. 189, 49-57 (2001).
14. Ferrari, G. et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279, 1528-1530 (1998).
15. Makino, S. et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103, 697-705 (1999).
16. Toma, C. et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98 (2002).
17. Shake, J.G. et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73, 1919-1925, 1926 (2002).
18. Reinecke, H., Zhang, M., Bartosek, T. & Murry, C.E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100, 193-202 (1999).
19. Zhang, M. et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 33, 907-921 (2001).
20. Muller-Ehmsen, J. et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J. Mol. Cell. Cardiol. 34, 107-116 (2002).
21. Franke, T.F., Kaplan, D.R. & Cantley, L.C. PI3K: downstream AKTion blocks apoptosis. Cell 88, 435-437 (1997).
22. Datta, S.R., Brunet, A. & Greenberg, M.E. Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927 (1999).
23. Colter, D.C., Class, R., DiGirolamo, C.M. & Prockop, D.J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc. Natl. Acad. Sci. USA 97, 3213-3218 (2000).
24. Hunnestad, J.A., Steen, R., Tjonnfjord, G.E. & Egeland, T. Thrombopoietin combined with early-acting growth factors effectively expands human hematopoietic progenitor cells in vitro. Stem Cells 17, 31-38 (1999).
25. Terada, N. et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416, 542-545 (2002).
26. Ying, Q.L., Nichols, J., Evans, E.P. & Smith, A.G. Changing potency by spontaneous fusion. Nature 416, 545-548 (2002).
27. Taylor, D.A. et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4, 929-933 (1998).
28. Murry, C.E., Wiseman, R.W., Schwartz, S.M. & Hauschka, S.D. Skeletal myoblast transplantation for repair of myocardial necrosis. J. Clin. Invest. 98, 2512-2523 (1996).
29. Atkins, B.Z. et al. Cellular cardiomyoplasty improves diastolic properties of injured heart. J. Surg. Res. 85, 234-242 (1999).
30. Menasche, P. et al. Myoblast transplantation for heart failure. Lancet 357, 279-280 (2001).
31. Reinecke, H., MacDonald, G.H., Hauschka, S.D. & Murry, C.E. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J. Cell. Biol. 149, 731-740 (2000).
32. Reinecke, H. & Murry, C.E. Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc. Pathol. 9, 337-(2000).
33. Li, R.K. et al. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation 96, 11-179-186, 186-177 (1997).
34. Watanabe, E. et al. Cardiomyocyte transplantation in a porcine myocardial infarction model. Cell Transplant. 7, 239-246 (1998).
35. Min, J.Y. et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92, 288-296 (2002).
36. Fujio, Y. et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101, 660-667 (2000).
37. Matsui, T. et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem. 277, 22896-22901 (2002).
38. Fukumoto, S. et al. Akt participation in the Wnt signaling pathway through Dishevelled. J. Biol. Chem. 276, 17479-17483 (2001).
39. Melo, L.G. et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105, 602-607 (2002).
40. Orlic, D. et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98, 10344-10349 (2001).
41. Nwogu, J. et al. Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction. Circulation 104, 2216-2221 (2001).
42. Choukroun, G. et al. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH2-terminal kinases. J. Clin. Invest. 104, 391-398 (1999).
43. Spindler, M. et al. Diastolic dysfunction and altered energetics in the αMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J. Clin. Invest. 101, 1775-1783 (1998).
44. Okano, J. et al. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. J. Biol. Chem. 275, 30934-30942 (2000).
45. Teruel, T., Hernandez, R. & Lorenzo, M. Ceramide mediates insulin resistance by tumor necrosis factor-α in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 50, 2563-2571 (2001).